SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
跳跃幻儿
Lv3
276 积分
2024-05-13 加入
最近求助
最近应助
互助留言
OA08.05 Tusamitamab Ravtansine vs Docetaxel in Previously Treated Advanced Nonsquamous NSCLC: Results from Phase 3 CARMEN-LC03 Trial
3天前
已完结
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
4天前
已完结
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR+/HER2- BC patients: results from the multicenter PALMARES-2 study
24天前
已完结
Comparing durvalumab, olaparib, and cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior bevacizumab: the phase II NRG-GY023 trial
25天前
已完结
Lessons from TROPiCS-04: ‘safety-first’ for success in late-stage clinical trials
25天前
已完结
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatin in patients with HER2-negative BC and HRD –long-term survival of the GeparOLA study
26天前
已完结
Lessons from TROPiCS-04: ‘safety-first’ for success in late-stage clinical trials
1个月前
已关闭
Final Survival Results from the Penelope-B trial investigating palbociclib vs placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy – PENELOPE-B
1个月前
已完结
Precision Endocrine Therapy in Endometrial Cancer: Has its time finally come?
1个月前
已完结
Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study
1个月前
已完结
Ceramide mediates cell-to-cell ER stress transmission by modulating membrane fluidity
1个月前
已采纳
Can Third-Party Brand Value Estimates Help Predict Cash Flows? A Machine-Learning Analysis
1个月前
已采纳
Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease
1个月前
已采纳
Targeted Next-Generation Sequencing in Succinate Dehydrogenase–Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway
3个月前
已采纳
Estimation of Mixing Coefficients using the Joint Probability Distribution of Mixed Signals
4个月前
已采纳
Recent Advances in Peptoids as Promising Antimicrobial Agents to Target Diverse Microbial Species
4个月前
已采纳
Teaching Texts
4个月前
已采纳
Anti-metastatic extracellular vesicles carrying DNA
4个月前
已采纳
Integrated metabolomic and transcriptomic analysis provides insights into the flavonoid formation in different Glycyrrhiza species
4个月前
已采纳
Abstract PO2-05-08: ISM5043, a novel, selective KAT6 inhibitor for the treatment of advanced and refractory ER+ breast cancer
4个月前
已采纳
感谢
2个月前
感谢
2个月前
感谢
3个月前
感谢
3个月前
应该是篇文章,而不是会议摘要
3个月前
感谢
3个月前
感谢
4个月前
感谢
4个月前
感谢
4个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论